MedTrace Logo

The Effect of Nasal Carbon Dioxide (CO2) in the Treatment of Mild Headache in People Who Experience Migraines

NCT00690716 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 292

Last updated 2012-08-15

No results posted yet for this study

Summary

The purpose of this study is to evaluate the safety and effect of nasal carbon dioxide in the treatment of mild headaches in people who have migraines.

Conditions

Interventions

DRUG

Nasal CO2

Adaptive Randomization to a Dosing Regimen for Treatment of a Qualifying Headache

DRUG

Inactive Placebo

Adaptive Randomization to a Dosing Regimen for Treatment of a Qualifying Headache

Sponsors & Collaborators

  • Capnia, Inc.

    lead INDUSTRY

Principal Investigators

  • Roger K. Cady, MD · Clinvest

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-08-31
Primary Completion
2009-06-30
Completion
2009-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00690716 on ClinicalTrials.gov